2190 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Zylox-Tonbridge Medical Technology Co., Ltd. engages in the production and sales of neurovascular and peripheral-vascular interventional surgical devices. The company was founded by Zhong Zhao on November 6, 2012 and is headquartered in Hangzhou, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
2190 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company